2025

Skip to Main Content

Order by

[P9] Nwankwo - Demographic and Survival Outcomes in Early Onset Pancreatic Neuroendocrine Tumors A National Cancer Database Study

Published in 2025 Listed under Population Science

[T10] Chauhan - NET RETREAT a CCTG SWOG Phase II Study of 177Lutetium Dotatate Retreatment vs Standard of Care in Metastatic GEPNET Patients

Published in 2025 Listed under Trials In Progress

[T11] Chauhan - A Phase 1 Trial of the Oncolytic Virus SVV 001 with Nivolumab and Ipilimumab in Patients with High Grade Neuroendocrine Neoplasms

Published in 2025 Listed under Trials In Progress

[T12] Pruitt (POSTER) - A Prospective Observational Study of GLP 1 and GLP 1 GIP Receptor Agonists in Patients with Well Differentiated Neuroendocrine Tumors

Published in 2025 Listed under Trials In Progress

[T12] Pruitt - A Prospective Observational Study of GLP 1 and GLP 1 GIP Receptor Agonists in Patients with Well Differentiated Neuroendocrine Tumors

Published in 2025 Listed under Trials In Progress

[T13] Ammabel Ynalvez - Stratification of Biochemical Response to Somatostatin Analogs in Carcinoid Syndrome Implications for Risk of Carcinoid Heart Disease

Published in 2025 Listed under Trials In Progress

[T14] Li - First in Human Study of a Novel Nonpeptide Drug Conjugate (CRN09682) in Patients With Somatostatin Receptor 2 Expressing Tumors

Published in 2025 Listed under Trials In Progress

[T15] Chauhan - ETCTN 10558 A Phase II Randomized Control Trial of Triapine Plus Lutetium 177 Dotatate Versus Lutetium 177 Dotatate Alone for Well Differentiated Somatostatin Receptor Positive Neuroendocrine Tumors

Published in 2025 Listed under Trials In Progress

[T1] Kunz (POSTER) - NETTER 3 [177Lu]Lu DOTA TATE in patients with newly diagnosed, Grade 1 2 (Ki 67 10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden

Published in 2025 Listed under Trials In Progress

[T1] Kunz - NETTER 3 [177Lu]Lu DOTA TATE in patients with newly diagnosed, Grade 1 2 (Ki 67 10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden

Published in 2025 Listed under Trials In Progress

[T2] Capdevila - STELLAR 311 A randomized phase 2 3 study of zanzalintinib versus everolimus in patients with previously treated advanced neuroendocrine tumors

Published in 2025 Listed under Trials In Progress

[T3] Chauhan - Obrixtamig (BI 764532) in relapsed refractory delta like ligand 3 (DLL3) high extrapulmonary neuroendocrine carcinoma Phase II DAREON® 5 dose expansion trial in progress

Published in 2025 Listed under Trials In Progress

[T4] Chauhan - CAREFNDR Phase 3, Randomized, Placebo Controlled Study of Paltusotine in Adults With Carcinoid Syndrome Due to Well Differentiated Neuroendocrine Tumors

Published in 2025 Listed under Trials In Progress

[T5] Mohamed - Trial in progress A Phase Ib II, Open label, Multi center Study of ZL 1310 in Participants with DLL3 positive Neuroendocrine Carcinomas (NECs) and other Selected Solid Tumors

Published in 2025 Listed under Trials In Progress

[T6] Soulen (POSTER) - Multicenter Phase 2 Trial of Yttrium 90 Radioembolization with Capecitabine Temozolomide for Grade 2 Liver Dominant Metastatic Neuroendocrine Tumors interim report

Published in 2025 Listed under Trials In Progress

[T6] Soulen - Multicenter Phase 2 Trial of Yttrium 90 Radioembolization with Capecitabine Temozolomide for Grade 2 Liver Dominant Metastatic Neuroendocrine Tumors interim report

Published in 2025 Listed under Trials In Progress

[T7] Narayan - Trial in Progress A Phase 2 Study of ONC206 in Patients with Advanced Pheochromocytoma and Paraganglioma

Published in 2025 Listed under Trials In Progress

[T8] Trikalinos - NCI 10479 A Phase I Dose Escalation Expansion Trial of Sunitinib Malate plus Lu 177 Dotatate in SSTR+ Pancreatic Neuroendocrine Tumors

Published in 2025 Listed under Trials In Progress

[T9] Hope - Alliance A021901 Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor Positive Bronchial Neuroendocrine Tumors

Published in 2025 Listed under Trials In Progress